Advanced search
Publication Cover
Acta Cardiologica Volume 77, 2022 - Issue 9
Submit an article Journal homepage
160
Views
2
CrossRef citations to date
0
Altmetric
Review Articles

For the love of muscles: a bodybuilder with complicated left ventricular heart failure

Lidwina De Turcka Department of Internal Medicine, AZ Sint-Blasius, Dendermonde, BelgiumCorrespondence[email protected]
,
Tom Sarensb Department of Cardiology, AZ Sint Blasius, Dendermonde, Belgium
,
Laurens Veldemanc Department of Endocrinology, AZ Sint Blasius, Dendermonde, Belgium
&
An Vonckd Department of Nephrology, AZ Sint Blasius, Dendermonde, Belgium
Pages 774-777 | Received 27 Oct 2021, Accepted 17 May 2022, Published online: 16 Aug 2022

References

  • Handelsman DJ. Androgen misuse and abuse. Endocr Rev. 2021;42(4):457–501.
  • Hartgens F, Kuipers H. Effects of Androgenic-Anabolic steroids in athletes. Sports Med. 2004;34(8):513–554.
  • Pope HG, Wood JRI, Rogol A, et al. Adverse health consequences of performance-enhancing drugs: an Endocrine Society scientific statement. Endocr Rev. 2014;35(3):341–375.
  • Doleeb S, Kratz A, Salter M, et al. Strong muscles, weak heart: testosterone-induced cardiomyopathy. ESC Heart Failure. 2019;6(5):1000–1004.
  • Baggish AL, Weiner RB, Kanayama G, et al. Long-Term Anabolic-Androgenic steroid use is associated with left ventricular dysfunction. Circ Heart Fail. 2010;3(4):472–476.
  • Shankara-Narayana N, Yu C, Savkovic S, et al. Rate and extent of recovery from reproductive and cardiac dysfunction due to androgen abuse in men. J Clin Endocrinol Metab. 2020;105(6):1827–1839.
  • Wang C. Recovery of reproductive and cardiac function in past androgen users. J Clin Endocrinol Metab. 2020;105(6):2284–2286.
  • Walker RF, Zakai NA, Maclehose RF, et al. Association of testosterone therapy with risk of venous thromboembolism among men with and without hypogonadism. JAMA Intern Med. 2020;180(2):190–197.
  • Chang S, Rasmussen JJ, Frandsen MN, et al. Procoagulant state in current and former anabolic androgenic steroid abusers. Thromb Haemost. 2018;118(4):647–653.
  • Baggish AL, Weiner RB, Kanayama G, et al. Cardiovascular toxicity of illicit anabolic-androgenic steroid use. Circulation. 2017;135(21):1991–2002.
  • Nili M, Deviri E, Jortner R, et al. Surgical removal of a mobile, pedunculated left ventricular thrombus: Report of 4 cases. Ann Thorac Surg. 1988;46(4):396–400.
  • Lattuca B, Bouziri N, Kerneis M, et al.; ACTION Study Group. Antithrombotic therapy for patients with left ventricular mural thrombus. J Am Coll Cardiol. 2020;75(14):1676–1685.
  • Robinson AA, Trankle CR, Eubanks G, et al. Off-label use of direct oral anticoagulants compared with warfarin for left ventricular thrombi. JAMA Cardiol. 2020;5(6):685–692.
  • Duarte IG, Fenton KN, Brown WM. Video-assisted removal of left ventricular mass. Ann Thorac Surg. 1997;63(3):833–835.
  • Cousin E, Scholfield M, Faber C, et al. Treatment options for patients with mobile left ventricular thrombus and ventricular dysfunction: a case series. Hear Lung Vessel. 2014;6(2):88–91.
  • Lee JM, Park JJ, Jung HW, et al. Left ventricular thrombus and subsequent thromboembolism, comparison of anticoagulation, surgical removal, and antiplatelet agents. J Atheroscler Thromb. 2013;20(1):73–93.
  • Engin C, Yagdi T, Balcioglu O, et al. Left ventricular assist device implantation in heart failure patients with a left ventricular thrombus. Transplant Proc. 2013;45(3):1017–1019.
  • Sabzi F, Faraji R. Large in-transient left ventricular thrombus due to anabolic steroid-induced cardiomyopathy. Indian J Crit Care Med. 2017;21(1):51–54.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Committed to improving the lives of patients with Type 2 Diabetes, Heart Failure and Chronic Kidney Disease.
Novartis. Your partner in Heart Failure & Atherosclerosis >>

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.